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Summary
Costimulatory signals from dendritic cells (DCs) are
required for naive T cells to respond to antigenic
stimulation. To what extent DCs reactivate memory T
cells during recall responses is not known. Here, an
in vivo depletion system has been used to analyze
the role of DCs in reactivating CD8 memory T cells
during recall responses to three different microbial
infections. We show a profound decrease in the num-
bers of responding memory CD8 T cells in both lym-
phoid and nonlymphoid tissues during the recall re-
sponses to infection with vesicular stomatitis virus,
Listeria monocytogenes (Lm), or influenza virus.
These data show that interaction with DCs is a major
mechanism driving T cell reactivation in vivo, even
during a tissue-specific infection of the respiratory
tract.
Introduction
CD8 T cells provide protection against a number of viral
and bacterial pathogens (Ahmed and Gray, 1996; Lin et
al., 2000). After an infection, naive CD8 T cells are
primed and undergo a rapid expansion phase followed
by a contraction period in which most effector cells are
eliminated, leaving a small, long-lived memory cell pool
(Ahmed and Gray, 1996). When rechallenged with an
infectious pathogen, antigen-specific memory T cells,
unlike naive T cells, can respond swiftly by robust pro-
liferation and upregulation of effector function (Bach-
mann et al., 1999a; Veiga-Fernandes et al., 2000; Zim-
mermann et al., 1999). Although the events required for
the initiation of a primary CD8 T cell response have
been extensively studied, the cellular and molecular
mechanisms that initiate and perpetuate an effective
memory CD8 T cell recall response are less well de-
fined. Analysis of the cellular requirements for generat-
ing a memory CD8 T cell recall response have focused
predominantly on the role of CD4 T cell help (Bourgeois
et al., 2002; Dirosa and Matzinger, 1996; Janssen et al.,
2003; Shedlock and Shen, 2003; Shedlock et al., 2003;
Sun and Bevan, 2003). The dependence of the antimi-
crobial CD8 T cell recall response on CD4 T cells has
been controversial. In some cases, CD4 T cells assist
the proliferative CD8 T cell recall response (Bourgeois
et al., 2002; Shedlock et al., 2003), whereas in other
situations, CD4 T cells appear to be dispensable for the
secondary response (Shedlock and Shen, 2003; Sun
and Bevan, 2003). These differences may be explained*Correspondence: llefranc@neuron.uchc.eduin part by the characteristics of the pathogen being
studied as well as perhaps by the infectious dose and
the mouse strain employed. Recent studies have also
suggested that CD8 memory T cell development is de-
pendent on the presence of CD4 T cells in the primary
response, but again, this has not been a universal find-
ing (Khanolkar et al., 2004; Marzo et al., 2004; Shedlock
and Shen, 2003; Sun et al., 2004; Sun and Bevan, 2003;
Shen et al., 2003).
Memory T cells are phenotypically and functionally
heterogenous, and the precursor-product relationships
among the different subsets is a topic of intense inter-
est. Two generally defined populations of memory cells
can be identified based primarily on tissue localization
and, in part, by phenotype and function (Masopust et
al., 2001; Sallusto et al., 1999; Seder and Ahmed, 2003).
Thus, effector memory cells are found in nonlymphoid
tissues such as the parenchyma of the lung and the
lamina propria (LP) of the intestine and, for CD8 T cells,
exhibit direct ex vivo lytic activity, whereas effector
memory CD4 T cells rapidly produce effector cytokines
(Masopust et al., 2001; Sallusto et al., 1999). In contrast,
central memory T cells are present in lymphoid tissues
and require reactivation to express effector function
(Sallusto et al., 1999), although at least in the mouse,
all CD8 memory T cells produce cytokines when stim-
ulated (Masopust et al., 2001; Unsoeld et al., 2002). Al-
though the expression patterns of cell surface homing
molecules such as CCR7 and CD62L were originally
suggested to define these subsets in human memory T
cells, a faithful phenotypic identification has yet to be
described, because memory cells with “effector” phe-
notypes can be found in lymphoid tissues. In addition,
blood-borne CD8 and CD4 memory T cells raised by
systemic infection rapidly equilibrate into lymphoid and
nonlymphoid tissues, suggesting that a common pool
of migrating memory T cells may exist (Klonowski et al.,
2004). Nevertheless, a recent report suggested that
CD8 memory T cell development follows a pathway
from naive to effector cell to effector memory cell fol-
lowed by reversion of effector memory cells to cells
with a central memory phenotype (Wherry et al., 2003).
In this scheme, the central memory CD8 T cell is pri-
marily responsible for maintaining long-ter m memory
and for mounting the proliferative recall response. How-
ever, effector memory CD8 T cells isolated from multi-
ple nonlymphoid tissues are able to respond vigorously
to infection after adoptive transfer (Masopust et al.,
2004), so it remains unclear whether memory cell sub-
sets develop along a continuum or represent distinct
lineages.
A rapid response by tissue-based memory T cells to
secondary infection makes teliological sense, because
such a response would presumably most effectively re-
move localized infection. Indeed, in cases where mem-
ory cells may be apposed directly with parenchymal
cells, such as in the intestinal or lung epithelium, it
might be expected that tissue-based memory cells
would respond directly to antigen presented by paren-
chymal cells. However, in the case of reactivation of
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nonhematopoietic tissue would be required, and in
some cases, such as in the intestinal epithelium, this
requirement is met (Hershberg et al., 1997; Vidal et al.,
1993). In addition, inflammation and infection can in-
duce MHC class II expression as well as upregulate
MHC class I levels (Hershberg et al., 1997). The concept
of memory cell reactivation by antigen expressed by
parenchymal tissue is supported by findings showing
that memory T cells are more readily activated than na-
ive T cells and that their reactivation may have altered
costimulation requirements (Bachmann et al., 1999b;
Bertram et al., 2004; Dawicki and Watts, 2004). Given
these findings, it has been postulated that memory T
cell recall responses are not DC dependent and that
other nonprofessional antigen-presenting cells (APCs)
may be sufficient for initiation of a secondary response
(Bachmann et al., 1999b; Bertram et al., 2004; Crowe et
al., 2003). Furthermore, during influenza infection of the
lungs, it has been suggested that the ability of cell
types other than DCs to present antigen skews the epi-
tope dominance of the response (Crowe et al., 2003).
Nevertheless, the role of DCs in mounting a secondary
response to infection has not been directly examined.
Our results now show that activation of memory T cells
in response to systemic or localized infection is pre-
dominantly, though not exclusively, dependent on DCs.
Results
Systemic Depletion of DCs in DTR Transgenic Mice
In order to selectively ablate DCs, we employed a pre-
viously described system in which the diptheria toxin
receptor (DTR) and green fluorescent protein (GFP) are
expressed under control of the CD11c promoter (Jung
et al., 2002). Treatment of these mice with DT results in
transient depletion of DCs. Unexpectedly, we found that
a single treatment of CD11c-DTR mice with DT (4 ng/g
body weight i.p.) resulted in the death of the transgenic F
mice in 6–7 days. However, when normal C57BL/6 mice a
were reconstituted with bone marrow from CD11c-DTR D
mice and were treated with the same dose of DT, no b
ddeleterious effects were observed even with prolonged
rDT treatment (data not shown). This result suggested
ethat essential nonhematopoietic cells expressed the
I
transgene and were effected by DT treatment. Thus, o
chimeric mice generated with CD11c-DTR bone mar- e
row were used for all of our studies. Because our goal i
ewas to examine recall responses in lymphoid and non-
elymphoid tissues, we examined the efficacy of DC de-
pletion in these sites. CD11c-DTR bone marrow chi-
meric mice or normal bone marrow chimeras were
winjected twice with DT (4 ng/g body weight i.p.) 3 days
tapart, and 24 hr later, tissues were analyzed for the
cpresence of DCs (Figure 1). As determined by flow cyto-
ometric analysis of the expression of CD11c and GFP by
ogated MHC class II+ cells, DCs in the spleen were re-
educed by w90% as previously reported (Jung et al.,
g2002; Crowe et al., 2003). DCs were also effectively de-
pleted in lymph node (LN) (pooled axillary, brachial, in-
guinal, and cervical nodes), lung, liver, and LP, although D
Nsmall populations of residual DCs were detected in
some cases. In all organs except the LP, a population B
of MHC class II+ GFP+ CD11c intermediate/low cellsigure 1. DCs Are Ablated in Lymphoid and Nonlymphoid Organs
fter DT Treatment
TR BM chimeras were injected with two doses of either 4 ng/g
ody weight DT or PBS 3 days apart and 24 hr later analyzed to
etermine the efficacy of DC ablation. Pooled samples of liver, pe-
ipheral LN, and LP from the two groups of mice were used to gain
nough numbers of DCs for analysis. DCs were identified as MHC
I+ CD11c+ GFP+ by flow cytometry, and the plots shown are gated
n MHC class II+ cells. DC numbers in all organs tested were gen-
rally depleted byw90% after treatment. The total number of DCs
s shown in each plot. Four mice were used per group and the
xperiment repeated twice. Data shown is representative of one
xperiment.ere detected that were ablated by DT treatment. Fur-
her analysis found this population to contain some B
ells and CD11c-low DCs, but not plasmacytoid DCs
r macrophages (data not shown). Whether expression
f GFP by these cells is a result of bona-fide CD11c
xpression or due to aberrant expression in the trans-
enic mice remains to be determined.
Cs Drive the Secondary Lymphoid and
onlymphoid Response to Lm Infection
ecause CD11c may be expressed by activated CD8 Tcells (Huleatt and Lefrançois, 1995; Jung et al., 2002;
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it is not possible to study endogenous memory cells
generated in the CD11c-DTR bone marrow chimeras.
To circumvent this problem, we transferred normal
C57BL/6-Ly5.2 DC-depleted splenocytes containing
memory T cells to the C57BL/6-Ly5.1 DTR chimeras.
Our previous results show that transferred splenic
memory T cells migrate effectively to the spleen, lung,
and liver but poorly to the intestinal LP (Masopust et
al., 2004). To address the role of DCs in the recall re-
sponse to systemic bacterial infection, we employed a
recombinant L. monocytogenes-expressing ovalbumin
(Lm-ova) (Pope et al., 2001) to allow us to monitor ova-
specific CD8 T cells. DC-depleted splenocytes contain-
ing Lm-ova-specific CD8+ splenic memory T cells were
transferred into DTR or wild-type (wt) chimeras, and the
mice were infected i.v. with Lm-ova the next day. DT
was administered every 3 days starting 4 days before
infection, and the recall response was analyzed 6 days
postinfection. It should be noted that DC depletion did
not alter memory cell migration to lymphoid and non-
lymphoid tissues (data not shown). In infected control
chimeras, a robust response by the transferred cells
was detected in all lymphoid and nonlymphoid tissues
tested (Figure 2A). Surprisingly, the recall response was
dramatically reduced in both lymphoid and nonlym-
phoid organs in DT-treated CD11c-DTR chimeric mice
(Figure 2A). The total number of antigen-specific cellsFigure 2. DCs Are Required for the Initiation of an Anti-Lm-Ova
Recall Response
DTR or wild-type (wt) bone marrow-reconstituted mice were
treated 4 and 1 days before infection with DT to ablate DCs in the
DTR mice. Ly5.2+ ova-specific CD8+ memory cells were transferred
into both groups 1 day before the mice were infected i.v. with 103
cfu Lm-ova. DT was administered every 3 days, and the mice were
analyzed 6 days after infection for Ly5.2+ ova-specific CD8+ T cells.
(A) The proportion of Ly5.2+ ova+ cells was decreased in all organs
analyzed. The numbers in the upper left corner of each panel repre-
sent percent of ova tet+ LFA+ cells among the donor CD8+ T cells.
(B) The total number of Ly5.2+ ova-specific cells is dramatically less
in the absence of DCs in all organs and was calculated from the
proportion of tet+ cells and total cellularity of each organ. The data
represent a total of six mice per group from two individual experi-
ments. All values are means ± SEM.in the spleen and LN was decreased by 98% and 95%,respectively (Figure 2B). This decrease was a reflection
of both a decreased frequency of antigen-specific cells
(Figure 2A) and in total antigen-specific cell number per
organ (Figure 2B). Similarly, the total numbers of anti-
gen-specific cells in the lung, liver, and LP were also
greatly reduced (93%, 97%, and 91%, respectively)
(Figure 2B). The massive reduction in the recall re-
sponse to Lm-ova in the absence of CD11c+ cells
strongly indicated that DCs are the primary APC re-
quired for a maximal recall response. We also examined
bacterial burdens in these mice, and although bacterial
titers were increased in the livers of DC-depleted mice
3 days after infection, by 6 days postinfection, Lm was
cleared from both control and CD11c-DTR chimeras
(Figure S1 available with this article online).
DCs Are Required for Optimal Secondary Lymphoid
and Nonlymphoid Recall Response to Vesicular
Stomatitis Virus Infection
Donor mice were infected with vesicular stomatitis
virus (VSV) in order to generate nucleoprotein (N)-spe-
cific memory T cells. DC-depleted splenocytes contain-
ing VSV-specific CD8 memory T cells were then trans-
ferred into DTR and wt chimeras, the mice were
challenged with VSV, and the recall response was ana-
lyzed 6 days later. The mice were treated with DT every
3 days starting 4 days before infection. Similar to what
we observed in the recall response to Lm infection, the
secondary response to VSV infection was dramaticallyFigure 3. DCs Are Required for the Initiation of an Anti-VSV Recall
Response
DTR or wt bone marrow-reconstituted mice were treated after the
protocol in Figure 2 except the mice were infected i.v. with 105 pfu
VSV. DT was administered every 3 days, and the mice were ana-
lyzed 6 days after infection for 5.2+ N tet+ CD8+ T cells.
(A) The proportion of Ly5.2+ N tet+ cells is decreased in all organs
analyzed to varying degrees. The numbers in the upper left corner
of each panel represent percent of N tet+ LFA+ cells among the
donor CD8+ T cells.
(B) The total number of Ly5.2+ N tet+ cells was calculated from the
proportion of tet+ cells and total cellularity of each organ. The data
is from one experiment of three mice per group, and the values are
means ± SEM. The experiment was repeated twice with similar re-
sults.reduced in the absence of DCs (Figure 3). The number
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Dof antigen-specific T cells in the spleen and LN were
treduced by 87% and 88%, respectively (Figure 3B).
pHowever, unlike in the secondary response to Lm-ova
winfection, this decrease was predominantly due to a de-
T
crease in total cellularity, as the percentage of antigen- (
specific cells was only decreased by 55% (spleen) and a
30% (LN) (Figure 3A). This trend was reflected in the u
clung, liver, and LP where the total number of antigen-
(specific cells was decreased by 81%, 86%, and 90%,
prespectively, yet the percentage of antigen-specific
r
cells was reduced by 21%, 41%, and 47%, respectively p
(Figures 3B and 3A, respectively). Although the reduc-
tion in the percentage of antigen-specific cells was not
as dramatic as that seen after Lm-ova challenge, these
rdata strongly supported an important requirement for
lDCs in generating an optimal recall response to VSV
sinfection. Nevertheless, the response observed in DC-
(depleted mice represented a significant expansion over
wunimmunized mice, suggesting that either residual DCs
iwere present or that other cells types could drive some
clevel of CD8 memory T cell reactivation.
a
tPeptide-Loaded DCs Restore the VSV Recall
tResponse in DC-Depleted CD11c-DTR Chimeras
tTo determine if the decreased proliferative recall re-
osponse after DT treatment was due to the loss of DCs
win this system, VSV N peptide-loaded DCs were adop-
stively transferred into DT-treated wt or DTR chimeras
ocontaining VSV N peptide-specific CD8 memory T cells.
8The introduction of peptide-loaded DCs led to a robust
(recall response in the DTR chimeras of an equivalent
tmagnitude to the wt control mice in both the lung (Fig-
pure 4) and the spleen (data not shown). These data
(demonstrated that the decreased CD8 memory T cell
wrecall response observed in DC-ablated mice could be
qrestored by introducing peptide-loaded DCs and fur-
tther indicated that the effects observed in CD11c-DTR
tchimeras were not due to any untoward direct or indi-
trect adverse effects of DT treatment.
c
The Recall Response to Tissue-Specific Infection
iExhibits Partial DC Dependence
cInfluenza virus infection is known to be primarily re-Figure 4. CD8 Memory T Cells Respond to Peptide-Loaded DCs in
DC-Depleted Mice
VSV-specific CD8 memory T cells (50,000) were transferred to the
indicated chimeras, and all were treated with DT on the day of
transfer. One day later, 5 × 105 purified splenic DCs (either coated
with the VSV N peptide or not) were transferred i.v. 6 days later, the
response in the lung (shown here) and the spleen (data not shown)
was measured by flow cytometry using an N peptide H-2Kb tetra-
mer. Data shown is gated on CD8+ T cells. Responses in the spleen,
though less robust, were similar between groups. Fstricted to the epithelium of the lungs, and a previouseport shows that in LTα−/− mice, which lack encapsu-
ated LN, an influenza virus-specific CD8 T cell re-
ponse could be generated albeit with delayed kinetics
Crowe et al., 2003; Lund et al., 2002). To address
hether lung infection could initiate a recall response
n the absence of DCs, Lm-ova-specific CD8 memory
ells were adoptively transferred into DT-treated DTR
nd wt mice, which were then infected intranasally with
he influenza strain WSN-ova (Topham et al., 2001). Ini-
ial experiments indicated that the recall response in
his system occurred slightly later than in either the Lm-
va or VSV models (data not shown), hence, the mice
ere sacrificed at day 8 and the magnitude of the re-
ponse analyzed. In DT-treated mice, the total number
f influenza virus-specific CD8 T cells was reduced by
6% in the lung parenchyma, 76% in the lung airways
BAL), 61% in the mediastinal LN (MedLN), and 79% in
he spleen (Figure 5B). Interestingly, whereas in the lung
arenchyma, BAL and spleen proportionate decreases
w80%) in the percentage of antigen-specific cells
ere noted, in the MedLN, aw50% increase in the fre-
uency of antigen-specific cells was noted as compared
o controls (Figure 5A). However, as the total cellularity of
he MedLN was significantly smaller in the DTR chimeras,
he actual number of antigen-specific CD8 T cells was
omparatively smaller than in wt animals (Figure 5B).
It is known that during the primary T cell response to
nfluenza virus infection, the increase in antigen-spe-
ific T cells is first observed in the MedLN before aigure 5. Partial DC Requirement for the Initiation of an Anti-Influ-
nza Recall Response
TR or wt bone marrow-reconstituted mice were treated following
he protocol in Figure 2 except the mice were infected i.n. with 103
fu WSN-ova. DT was administered every 3 days, and the mice
ere analyzed 8 days after infection for Ly5.2+ ova-specific CD8+
cells.
A) The proportion of Ly5.2+ ova+ cells is decreased in all organs
nalyzed with the exception of the MedLN. The numbers in the
pper left corner of each panel represent percent of ova tet+ LFA+
ells among the donor CD8+ T cells.
B) The total number of Ly5.2+ ova+ cells was calculated from the
roportion of tet+ cells and total cellularity of each organ,. The data
epresents five mice (wt) or six mice (DTR) from two individual ex-
eriments. All values are means ± SEM.noticeable increase is detected in the lung parenchyma
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the MedLN showed the smallest reduction in the prolif-
erative recall response, the possibility existed that the
response in the DTR chimeras was delayed compared
to control mice, comparable to what has been ob-
served in the primary anti-influenza virus CD8 T cell re-
sponse in LTα−/− mice (Lund et al., 2002). To test this,
cohorts of influenza virus-infected DTR and wt chime-
ras were sacrificed 11 days after infection. In all cases,
the infected DTR chimeras exhibited signs of respira-
tory distress by day 11, whereas wt animals appeared
normal, suggesting that DCs are required for protection
against infection in this setting. Indeed, on days 5 and
8 after infection, the lungs of DC-depleted mice con-
tained w100- to 1000-fold greater viral loads than did
control mice (Figure S1). The number of antigen-spe-
cific T cells in the spleen and lung airways remained
substantially decreased compared to wt controls (84%
and 80%, respectively) despite an equivalent total cel-
lularity in these organs (Figures 6B and 6A, respec-
tively). Furthermore, the total number of antigen-spe-
cific cells in the spleen and airways of both wt and DTR
mice had increased from day 8 to day 11, whereas in
the lung parenchyma, the number had decreased dur-
ing this time. Interestingly, unlike at day 8, the response
in the lung parenchyma was not reduced by the abla-
tion of DCs (Figure 6B). This effect was due in part to
an increase in the overall cell numbers in DT-treated
mice, because the proportion of antigen-specific cells
in these mice was half that present in wt chimeras (Fig-
ure 6A and data not shown). In DT-treated mice at day
11 postinfection, the total cellularity of the MedLN was
dramatically lower than that observed on day 8 (FigureFigure 6. The Reduced Recall Response to Influenza Is Delayed in
the Absence of DCs
(A) The total cellularity of the lungs, BAL fluid, and spleen is equal
in the DTR and wt mice, 11 days after infection. The cellularity of
the MedLN is still dramatically reduced at this time point.
(B) Despite the equal total cellularity in the BAL fluid and spleen,
there is still a reduced number of ova+ CD8+ cells in these organs.
By day 11, the number of ova+ CD8+ cells in the lungs of wt and
DTR mice are comparable. The data represent six mice (wt) or
four mice (DTR) from two individual experiments. All values are
means ± SEM.5A). Although the total number of antigen-specific cellscould not be accurately determined, the approximate
values obtained were also significantly lower than
those observed on day 8 (data not shown). Combined,
these data demonstrated that without DCs to initiate a
recall response to influenza virus infection, neither
other APCs nor infected lung epithelium could generate
a recall response of similar magnitude to that seen in
DC-sufficient wt mice.
Kinetics of DC Requirements
during the Recall Response
The first 24 hr after infection has been identified as a
critical period for the initiation of a naive CD8+ T cell
response to infectious agents (Van Stipdonk et al.,
2003; Mercado et al., 2000; Kaech and Ahmed, 2001).
In order to determine when DCs are required during ini-
tiation of a secondary response, ova-specific memory
CD8+ T cells were transferred into either wt or DTR
bone marrow chimeras, and the DCs were ablated at 0,
1, 2, 3, or 5 days after infection with VSV-ova. Depletion
of DCs at the time of infection resulted in a greatly re-
duced (88%) recall response in the spleen (Figure 7A).
A similar decrease in the response was observed when
the DCs were ablated 24 hr after infection. Surprisingly,
even when DCs were removed 48 hr after the second-
ary challenge, the response was reduced to 47% of the
equivalent wt response (Figure 7A). From this initial
data, the time before DT treatment was extended. As
before, depletion of DCs at the time of infection re-
sulted in a greatly reduced (93%) recall response in the
spleen (Figure 7B). When DCs were ablated 24 hr after
infection, the response was inhibited by 73% in the ex-
periment shown. When DCs were depleted on day 3 or
5, the inhibition observed was not significant. These
data indicated a continuing requirement for DCs over
at least the first 2 days after infection in order for the
generation of a maximum recall response.
The inhibition of the memory response could be the
result of decreased recruitment of memory cells into
the response and/or due to reduced expansion. To test
these possibilities, memory cells were carboxyfluores-
cein diacetate succinimidyl ester (CFSE) labeled prior
to transfer, and DT was administered at the time of in-
fection (the treatment resulting in the greatest inhibi-
tion). Interestingly, 6 days after infection, nearly all
memory cells in control and CD11c-DTR chimeras had
lost CFSE (Figure 7C). In addition, in terms of total cell
numbers, w2-fold more CFSE bright-tetramer+ cells re-
mained in the spleens of CD11c-DTR chimeras as com-
pared to control mice (Figure 7C and data not shown).
Because this difference is unlikely to account for the
level of inhibition observed, decreased overall prolifera-
tion and/or decreased survival of responding memory
cells may have also contributed to the reduced re-
sponse.
Reactivation of Central versus Effector
Memory Cells
Although we observed a DC requirement in the CD8
recall response in all tissues, it remained possible that
memory cell subsets were differentially DC dependent.
In the studies above, transferred memory cells were com-
prised of w85% CD62Llow and 15% CD62Lhigh memory
cells, so the responses we measured were perhaps pre-
Immunity
566b
s
p
w
D
T
r
s
r
s
o
e
A
a
o
D
(
m
T
n
c
t
s
M
Figure 7. DCs Are Required for More than 48 hr to Generate a Full a
Recall Response f
(A) Ly5.2+ ova -specific CD8+ memory cells were transferred into t
both groups of mice 1 day before the mice were infected i.v. with s
105 pfu VSV-ova. A single dose of DT was administered at either
tday 0, 1, or 2 of infection and CD8+ Ly5.2+ ova-tet+ cells in the
aspleens were quantitated six days after infection. The percent de-
1crease was calculated based on total tet+ cell numbers in each
group. The data represent four mice in each group from two indi- r
vidual experiments. s
(B) CFSE-labeled Ly5.2+ VSV N protein-specific CD8+ memory cells
were transferred into the indicated chimeras 1 day before the mice
twere infected i.v. with 105 pfu VSV. A single dose of DT was admin-
listered at either day 0, 1, 3, or 5, and CD8+ Ly5.2+ N tet+ cells in
Othe spleens were quantitated six days after infection. Values repre-
sent total tet+ cells from three mice per group. p
(C) CFSE analysis of the mice in (B) treated at day 0 with DT. Analy- F
sis is of gated Ly5.2+ CD8+ tet+ cells. The total number of CFSE- t
high cells is indicated.
g
i
bdominantly mediated by CD62Llow cells. However, it
has been reported that CD62Llow CD8 memory cells do m
tnot respond as robustly as CD62Lhigh memory cells. To
test this in our system, we transferred similar numbers N
cof splenic memory cells that had been sorted based on
CD62L expression into B6 control or CD11c-DTR bone C
emarrow chimeras. After DT treatment and i.v. VSV infec-
tion, the expansion of the transferred memory cells was (
cmeasured (Figure S2). The expansion of CD62Llow and
CD62Lhigh memory cells was similar in the spleen, lung, i
tand liver. This result is in contrast to a previous report
using vaccinia virus challenge of transferred LCMV- t
rspecific memory cells (Wherry et al., 2003) in which ex-
pansion of CD62Lhigh cells substantially outpaced that a
aof CD62Llow memory cells. When DCs were depleted,
the response of CD62Lhigh memory cells was inhibited p
Mw90% in all tissues. Interestingly, the response by
CD62Llow memory cells was less DC dependent, with r
winhibition of w60%–80%. Although further studies wille needed to learn the basis of this difference, the re-
ults support the intriguing possibility that nonlym-
hoid memory cells are more readily able to interact
ith nonprofessional APCs.
iscussion
he data presented in this study identified an important
ole for DCs in generating efficient memory recall re-
ponses to multiple pathogens. Thus far, a potential
ole for DCs in mounting a secondary CD8 T cell re-
ponse to infection has not been described. Indeed,
nly limited data are available with regard to the role of
ndogenous DCs in initiating immune responses in vivo.
lthough the transfer of antigen-loaded, in vitro-gener-
ted DCs has been used to drive responses in vivo,
nly recently has a system become available to study
C involvement in immune response initiation in situ
Jung et al., 2002). This system was employed to de-
onstrate a DC requirement for driving a primary CD8
cell response in the spleen to Lm infection. We have
ow utilized this model to analyze the secondary CD8 T
ell response to various infectious agents. Considering
hat many memory cells are located in nonlymphoid tis-
ues and are closely apposed to potentially infected
HC class I-bearing parenchymal cells (Masopust et
l., 2001), we reasoned that DCs might be dispensable
or secondary immune response initiation. Moreover,
he lower activation threshold of memory CD8 T cells
uggests that costimulation may not be required, and
hus, nonprofessional APCs could mediate reactivation
s has been previously suggested (Bachmann et al.,
999b). However, our results indicated an important
ole for DCs in activation of CD8 memory T cells after
econdary infection.
Our findings demonstrated that the recall response
o Lm infection was decreased >90% in all organs ana-
yzed when DCs were depleted at the time of infection.
ther effects of the absence of DCs in our system have
otential to influence the CD8 T cell recall response.
or example, DC removal could affect lymphoid archi-
ecture and thus the location of memory T cells. Distin-
uishing such effects from the role of DCs themselves
n memory cell reactivation, however, will be difficult if
oth occur simultaneously. In addition, DC ablation
ay also prevent the DCs from acting as a conduit be-
ween the helper CD4 T cell and the CD8 memory cell.
evertheless, the inhibition of the Lm-specific CD8 T
ell response could not be solely attributed to a loss of
D4 T cell help, because depletion of CD4 T cells gen-
rally reduces the CD8 T cell recall response byw50%
Marzo et al., 2004). Thus, our data indicated that other
ell types such as macrophages, which can be directly
nfected by Lm (Unanue, 1997), were unable to replace
he role provided by DCs after Lm rechallenge. Unlike
he recall response to Lm, the secondary CD8 T cell
esponse to VSV is not CD4 T cell dependent (Marzo et
l., 2004; Sun et al., 2004), and VSV is thought to infect
wide range of cell types. Hence, many cell types are
otentially capable of presenting viral antigens via
HC class I. Nevertheless, in the absence of DCs, the
ecall response to VSV infection was reduced by
81%–90% in all organs analyzed. Although this is a
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567dramatic reduction compared to control mice, the re-
sponse obtained is nevertheless the result of a signifi-
cant increase in the numbers of antigen-specific cells
that were originally transferred, and this was the case
for Lm and influenza virus recall responses as well. This
finding suggested that either not all DCs were depleted
by DT treatment or that other APCs or parenchymal
cells were involved in antigen presentation and activa-
tion of memory cells. Importantly, the reduced recall re-
sponses were not due to any unintended effects of DT
treatment, as the VSV N peptide recall response could
be restored in our model by the transfer of N peptide-
loaded DCs. Likewise, it seems unlikely that the small
population of GFP+ CD11clow B cells deleted by DT
treatment contributed substantially to the decreased
memory recall responses observed, although this has
not been formally excluded.
In the case of influenza virus, infection is known to
occur primarily in the epithelial lining of the lungs (Col-
lins et al., 2004). Hence, the initiation of a primary im-
mune response is thought to occur when antigen-
loaded DCs migrate to the draining mediastinal LN
(Banchereau and Steinman, 1998). However, a recent
study demonstrates that in mice lacking the spleen and
LN, the primary CD8 T cell response to influenza virus
infection can be initiated, with delayed kinetics, in
bronchus associated lymphoid tissue (BALT), whose
formation is induced by the infection (Lund et al., 2002;
Moyron-Quiroz et al., 2004). In our experiments, al-
though many influenza virus-specific memory cells are
located in the lung parenchyma, the recall response to
infection was reduced by w60%–90% in the various
organs analyzed. Like in the studies by Lund et al.
(2002), a delayed increase in total antigen-specific cells
in the lung parenchyma, BAL, and spleen was ob-
served. Thus, the number of antigen-specific cells in
the parenchyma doubled in the DT-treated mice be-
tween days 8 and 11 after infection, whereas increases
of 54% and 85% were observed in the BAL and spleen,
respectively. In contrast, the response in control mice
decreased during this time in the lung parenchyma,
presumably due to clearance of the infection. Both the
BAL and spleens of the control mice exhibited slight
increases in antigen-specific cells though not of the
same magnitudes as that seen in the DTR mice. De-
spite an increase in antigen-specific cells in the BAL,
the response was still considerably lower when DCs
were removed, although there was an equivalent total
cellularity compared to control BAL fluid. The large cell
number in the DT-treated animals was a reflection of
the nonspecific recruitment of cells into the lung air-
ways due to inflammation (Ely et al., 2003). In any case,
the results suggested that as compared to secondary
responses to VSV and Lm infection, the recall response
to influenza virus infection was less dependent on DCs.
In accordance with this finding, a previous report exam-
ining epitope dominance in the CD8 T cell response
to influenza virus infection suggested that non-DCs are
involved in initiation of at least a portion of the second-
ary response (Crowe et al., 2003). Despite this result,
protection against infection was clearly DC dependent
(Figure S1).
Whether DC-dependent recall responses are being
initiated in the BALT, LN, or nonlymphoid tissue is un-known, but our results suggested that at least some
measure of memory cell activation may occur in the
parenchymal tissues, and further, that effector memory
cells in these tissues were responding to secondary
challenge. A recent study suggests that although effec-
tor and central memory T cells both exhibit rapid effec-
tor function, central memory T cells are more proficient
at mounting a proliferative recall response (Wherry et
al., 2003). In contrast, our results showed that splenic
CD62Lhigh and CD62Llow memory cells both mounted
robust recall responses in response to VSV infection
(Figure S2). Moreover, effector memory cells in the lung
can mount a vigorous proliferative recall response to
respiratory virus infection, perhaps more effectively
than central memory cells (Roberts and Woodland,
2004). Interestingly, CD62Llow memory cells were less
dependent on DCs for reactivation than were CD62Lhigh
cells. This may be due to a greater DC requirement for
activation of lymphoid versus nonlymphoid memory
cells, though additional analysis is required to address
this possibility. Whether DCs, non-DC APCs, or paren-
chymal tissues are capable of inducing effector func-
tions in either memory T cell population remains to be
seen and is a subject of further investigation.
Our findings also shed light on the duration of mem-
ory cell-DC interaction required for optimal reactivation
after VSV infection. Not surprisingly, DCs were essential
in the first 24 hr of the recall response. However, sub-
stantial DC dependence was noted when DCs were re-
moved 24 and 48 hr after infection. Whether this effect
was the result of disruption of preexisting T cell-DC
conjugates or due to inhibition of formation of new in-
teractions will require analysis with in situ visualization
techniques. These results were perhaps unexpected
given the current data for naive CD8 T cell activation,
which suggests that a short (<24 hr) encounter with an-
tigen is sufficient to drive an optimal response (Badovi-
nac et al., 2002; Kaech and Ahmed, 2001; Mercado et
al., 2000; Van Stipdonk et al., 2001). Because memory
cells respond more rapidly than do naive T cells, one
would not expect memory cells to require a longer period
of antigen stimulation to reach a full response. The differ-
ences observed may be due to the use of in vitro systems
in some cases and the incomplete removal of antigen/
APCs in the in vivo studies. For example, in a study of
naive CD8 T cell activation, removal of infectious Lm by
antibiotic treatment 24 hr after infection did not affect
the overall CD8 T cell response (Mercado et al., 2000).
In our model, the infectious agent was not removed, but
the means to present antigen via DCs was eliminated at
various time points after infection. Thus, as previously
noted (Mercado et al., 2000), removal of the pathogen
in vivo does not remove DCs that are primed and
loaded with antigen, and our data indicated that, at
least for memory T cells, antigen presentation by DCs
is required for more than 24 hr in order to drive the
maximal proliferative response of memory CD8 T cells.
By relying on DCs to initiate a recall response, the
immune system adds a layer of protection against auto-
reactivity in the same manner as it does for naive T
cells. The rapidity and strength of the recall response,
which are the advantages gained in having memory T
cells, occur primarily by increased sensitivity at the
level of the T cell without sacrificing the need for anti-
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568cgen presentation by DCs. The relative contribution of
eother potential APCs, professional or otherwise, in
emounting and sustaining the recall response remains
t
the focus of further investigation. t
d
Experimental Procedures i
e
Mice
C57Bl/6 (CD45.2) mice were purchased from the Jackson Labora- K
tory (Bar Harbor, ME) and C57Bl/6 (CD45.1) mice were purchased a
from Charles River through the NCI program (Bethesda, MD). DTR D
transgenic mice were a gift from Drs. Steffen Jung and D. Littman C
(Skirball Institute, New York, NY). The mice were backcrossed ten d
times to C57Bl/6 at the UCONN Health Center facilities. DTR Tg+ T
mice were screened by PCR from tail DNA as previously described o
(Jung et al., 2002). Mice were maintained in specific pathogen-free t
conditions and handled under protocols approved by the UCHC
Animal Care Committee according to federal guidelines. C
L
Bone Marrow Chimeras s
Femurs and tibias were taken from DTR Tg+ mice or non-Tg+ litter- P
mates. The bone marrow was flushed out with a syringe and a
passed through a 70 m nylon mesh to generate a single-cell sus- o
pension. Red blood cells (RBCs) were lysed, and the cells resus- r
pended in HBSS supplemented with HEPES, L-glutamine, penicil- m
lin, streptomycin, and gentamycin sulfate (HBSS-HGPG). To C
remove mature T cells from the bone marrow, cells were incubated a
with anti-Thy1 ascites fluid (T24), washed once in HBSS-HGPG, F
then incubated with Low-Tox-M rabbit complement (Cedarlane L
Laboratories, Ontario, Canada) for 45 min at 37°C. Cells were b
washed twice and resuspended between 10 × 106 cells/ml and m
25 × 106 cells/ml. CD45.1 recipient B6 mice were irradiated (1000 s
rad) before 2 × 106 to 5 × 106 bone marrow cells were transferred D
i.v. The mice were allowed to rest for 8 weeks before use.
R
DT Treatment of Mice D
DT (Sigma, St Louis, MO) was administered to mice at 4 ng/g body- S
weight, in saline, i.p. To determine the efficacy of DC ablation, two g
doses of DT were administered 3 days apart to DTR bone marrow m
chimeras, and 24 hr later, various organs were analyzed by flow m
cytometry for the presence of CD11c+, MHC class II+ GFP+ cells. i
DT treatment of DTR or wt BM chimeras for memory cell recall t
experiments consisted of two doses of DT prior to pathogen re- f
challenge and was administered every 3 days for the duration of 3
the experiments. c
w
aGeneration of Memory Cells and Adoptive Cell Transfer
VB6 mice were infected with either Lm-ova (103 cfu i.v.) or VSV (Indi-
wana strain, 105 pfu i.v.). The mice were rested for 35–60 days to
callow for the formation of memory cells. Spleens were then har-
vested and crushed between glass slides, the RBC lysed, and the
remaining lymphocytes washed in HBSS-HGPG. Cells were then
Sincubated with an anti-MHC class II mAb (M5), incubated on ice for
S20 min, and washed before being mixed with beads coupled to
aanti-rat IgG and anti-mouse IgG (Dynal, Oslo, Norway). Unwanted
5MHC class II+ cells and B cells were then removed by magnetic
separation. The cells were then analyzed for the number of CD8+
memory cells, CD4 cells, B cells, NK cells, and DCs by flow cytom-
Aetry. Cells for adoptive transfer had typically less than 0.2% DCs
after purification. For analysis of division history, cells were resus-
Tpended in HBSS/HEPES, L-Glutamine, Pen/Strep, and gentamycin
Dsulfate (HGPG) at a concentration of 10 × 106 cells/ml and warmed
ato 37°C. 5- (and 6-) CFSE (Molecular Probes, Eugene, OR) was
fadded to the cell suspension at a final concentration of 5 M and
incubated for 10 min at 37°C (Lyons and Parish, 1994). Cells were
washed with HBSS/10% FCS then resupended in PBS prior to i.v. R
injection. R
A
Requirements for DCs in Memory Recall Responses P
and Protection
DTR or wt BM chimeras received DT at day −4 and day −1 before R
rechallenge with a pathogen. At day −1, DC-depleted splenocytes
+containing w20,000–40,000 memory CD8 T cells were transferred
i.v., and one day later, mice were infected with either Lm-ova (103fu i.v.), VSV (Indiana strain, 105 pfu i.v.); or the WSN strain of influ-
nza virus (103 pfu i.n.) containing the SIINFEKL epitope (Topham
t al., 2001). Lymphocytes were harvested from various organs at
he indicated days and analyzed by flow cytometry. Influenza virus
iters were measured from homogenized lung tissue as previously
escribed (Tobita et al., 1975). Colony-forming units (cfus) of Lm in
nfected tissues were quantitated as previously described (Marzo
t al., 2002).
inetics of DC Requirements in Generating
Memory Recall Response
C-depleted splenocytes containing ova- or VSV-specific memory
D8+ T cells were transferred into DTR and wt BM chimeras one
ay before infection with either VSV-ova or wt VSV (105 pfu i.v.).
he mice then received a single dose of DT at either day 0, 1, 2, 3,
r 5 after infection. At day 6, the lymphocytes were harvested from
he spleen, and the recall response was analyzed by flow cytometry.
ell Surface Staining and Flow Cytometry Analysis
ymphocytes were prepared from various organs as previously de-
cribed (Klonowski et al., 2004). They were then resuspended in
BS with 1% BSA and 0.01% NaN3 at 1 × 106 to 5 × 106 cells/tube
nd incubated at 4°C in 50 l of the appropriately diluted cocktail
f monoclonal antibodies. MHC class I tetramer staining was car-
ied out for 60 min at room temperature. The following conjugated
Abs were used: anti-CD11c-biotin, anti-MHC class II-PE, anti-
D45.1-PE, anti-CD8-PERCP, anti-CD11a-FITC, anti-CD4-APC,
nti-B220-PE, anti-DX5-PE, anti-CD11c-PE, and anti-MHC class II-
ITC (Pharmingen, San Diego, CA). Streptavidin-PE-CY7 (Caltag
aboratories, Burlingame, CA) was used to detect biotinylated anti-
odies. Antigen-specific CD8 T cells were detected with ova-tetra-
er APCs and N-tetramer APCs. The relative fluorescence inten-
ities of the cells were measured by using a FACSCalibur (Becton
ickinson, San Jose, CA).
estoration of the Recall Response by Peptide-Loaded
C Adoptive Transfer
pleens from B6 mice were chopped into small pieces and di-
ested in 5 ml HBSS/HGPG containing 5% FCS, collagenase D (1
g/ml), and DNase I (0.02 mg/ml) (Roche, Indianapolis, IN) for 30
in at 37°C before being pushed through a cell strainer. DCs were
solated by using CD11c MACS beads and an LS25 column (Mil-
enyi Biotech, Auburn, CA) per the manufacturer protocol. The puri-
ied DCs were coated with 2 g/ml VSV N peptide for 45 min at
7°C and washed twice before transfer. DC-depleted splenocytes
ontaining w50,000 VSV N peptide-specific memory CD8+ T cells
ere transferred into DT-treated CD11c-DTR and wt BM chimeras,
nd the next day, 5 × 105 purified splenic DCs, either coated with
SV N peptide or not, were adoptively transferred. Lymphocytes
ere harvested from the spleen and lungs and analyzed by flow
ytometry 6 days later.
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upplemental data include two figures and are available with this
rticle online at http://www.immunity.com/cgi/content/full/22/5/
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